Valeria Bianconi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Valeria Bianconi has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Chiara Mozzetta
IRCCS Fondazione Santa Lucia, Rome, Italy
2 shared publications - Beatrice Biferali
Gene Expression Regulation Unit, Division of Genetics and Cell Biology, IRCCS Ospedale San Raffaele, Milan, Italy
1 shared publication Carlo Toniatti
IRBM Science Park, Via Pontina Km 30.600, 00070 Pomezia, Italy
1 shared publication- Cristina Limatola
Department of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy
1 shared publication Daniel Fernandez Perez
Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy
1 shared publication- Diego Pasini
European Institute of Oncology
1 shared publication
Latest Publications
- Open Access
Muscle Damage in Dystrophic mdx Mice Is Influenced by the Activity of Ca2+-Activated KCa3.1 Channels
Duchenne muscular dystrophy (DMD) is an X-linked disease, caused by a mutant dystrophin gene, leading to muscle membrane instability, followed by muscle inflammation, infiltration of pro-inflammatory macrophages and fibrosis. The calcium-activated potassium channel type 3.1 (KCa3.1) plays key roles in controlling both macrophage phenotype and fibroblast proliferation, two critical contributors to muscle damage. In this work, we demonstrate that pharmacological blockade of the channel in the mdx mouse model during the early degenerative phase favors the acquisition of an anti-inflammatory phenotype by tissue macrophages and reduces collagen deposition in muscles, with a concomitant reduction of muscle damage. As already observed with other treatments, no improvement in muscle performance was observed in vivo. In conclusion, this work supports the idea that KCa3.1 channels play a contributing role in controlling damage-causing cells in DMD. A more complete understanding of their function could lead to the identification of novel therapeutic approaches.
Open AccessMuscle Damage in Dystrophic mdx Mice Is Influenced by the Activity of Ca2+-Activated KCa3.1 Channels
Duchenne muscular dystrophy (DMD) is an X-linked disease, caused by a mutant dystrophin gene, leading to muscle membrane instability, followed by muscle inflammation, infiltration of pro-inflammatory macrophages and fibrosis. The calcium-activated potassium channel type 3.1 (KCa3.1) plays key roles in controlling both macrophage phenotype and fibroblast proliferation, two critical contributors to muscle damage. In this work, we demonstrate that pharmacological blockade of the channel in the mdx mouse model during the early degenerative phase favors the acquisition of an anti-inflammatory phenotype by tissue macrophages and reduces collagen deposition in muscles, with a concomitant reduction of muscle damage. As already observed with other treatments, no improvement in muscle performance was observed in vivo. In conclusion, this work supports the idea that KCa3.1 channels play a contributing role in controlling damage-causing cells in DMD. A more complete understanding of their function could lead to the identification of novel therapeutic approaches.
- Open Access
- 4 June 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (23) , eabd9371
Prdm16-mediated H3K9 methylation controls fibro-adipogenic progenitors identity during skeletal muscle repair
A druggable mechanism is found to reprogram fibro-adipogenic progenitors toward myogenesis and to improve muscle repair.
- 4 June 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (23) , eabd9371
Open AccessPrdm16-mediated H3K9 methylation controls fibro-adipogenic progenitors identity during skeletal muscle repair
A druggable mechanism is found to reprogram fibro-adipogenic progenitors toward myogenesis and to improve muscle repair.